Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Next Wave Ventures in connection with the acquisition of Rexam Plc’s Petainer operations
Mandate

Vinge advises Next Wave Ventures in connection with the acquisition of Rexam Plc’s Petainer operations

November 23, 2009

Vinge has advised Next Wave Ventures in the acquisition by Next Waves and WHEB Ventures of Rexam Plc’s Petainer operations in Sweden, the Czech Republic and Germany for approximately SEK 190,000,000 (GBP 16,000,000).

Rexam’s Petainer operations manufacture PET beverage containers. The facilities in Lidköping and the Czech Republic have 250 employees and a combined turnover of SEK 700 million. These facilities primarily supply PET bottles to the Nordic and German markets. Next Wave is an English private equity and venture capital firm focused on investing in UK and European small cap companies and WHEB invests in companies focusing on environmentally friendly technology and sustainable solutions.

The Vinge team advising Next Wave consisted of partner Jesper Ottergren together with, among others, associates Anna Bjering, Magnus Bigner, Anna Bergstrand, Susanne Samuelsson and Ida Christensson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025